Alcon Income from Continuous Operations 2019-2025 | ALC
Alcon annual/quarterly income from continuous operations history and growth rate from 2019 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
- Alcon income from continuous operations for the quarter ending March 31, 2025 was $350M, a 41.13% increase year-over-year.
- Alcon income from continuous operations for the twelve months ending March 31, 2025 was $1.120B, a 6.87% increase year-over-year.
- Alcon annual income from continuous operations for 2024 was $1.018B, a 4.52% increase from 2023.
- Alcon annual income from continuous operations for 2023 was $0.974B, a 190.75% increase from 2022.
- Alcon annual income from continuous operations for 2022 was $0.335B, a 10.9% decline from 2021.
| Alcon Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $1,018 |
| 2023 | $974 |
| 2022 | $335 |
| 2021 | $376 |
| 2020 | $-531 |
| 2019 | $-656 |
| 2018 | $-227 |
| Alcon Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2025-03-31 | $350 |
| 2024-12-31 | $284 |
| 2024-09-30 | $263 |
| 2024-06-30 | $223 |
| 2024-03-31 | $248 |
| 2023-12-31 | $427 |
| 2023-09-30 | $204 |
| 2023-06-30 | $169 |
| 2023-03-31 | $174 |
| 2022-12-31 | $-97 |
| 2022-09-30 | $116 |
| 2022-06-30 | $148 |
| 2022-03-31 | $168 |
| 2021-12-31 | $139 |
| 2021-09-30 | $2 |
| 2021-06-30 | $151 |
| 2021-03-31 | $84 |
| 2020-12-31 | $95 |
| 2020-09-30 | $-147 |
| 2020-06-30 | $-422 |
| 2020-03-31 | $-57 |
| 2019-12-31 | $-91 |
| 2019-09-30 | $-66 |
| 2019-06-30 | $-390 |
| 2019-03-31 | $-109 |
| 2018-12-31 | |
| 2018-09-30 | $-207 |
| 2018-06-30 | $15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $42.809B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.157B | 22.16 |
| Intuitive Surgical (ISRG) | United States | $171.022B | 70.89 |
| IDEXX Laboratories (IDXX) | United States | $52.319B | 54.45 |
| Edwards Lifesciences (EW) | United States | $45.899B | 30.42 |
| IQVIA Holdings (IQV) | United States | $32.198B | 18.19 |
| DexCom (DXCM) | United States | $31.357B | 47.03 |
| Mettler-Toledo (MTD) | United States | $27.060B | 32.12 |
| STERIS (STE) | Ireland | $24.242B | 25.80 |
| Waters (WAT) | United States | $17.472B | 24.00 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.672B | 0.00 |
| Hologic (HOLX) | United States | $15.138B | 16.40 |
| Penumbra (PEN) | United States | $9.875B | 72.14 |
| Sysmex ADR (SSMXY) | Japan | $8.441B | 26.82 |
| Masimo (MASI) | United States | $8.250B | 27.76 |
| Globus Medical (GMED) | United States | $8.125B | 18.70 |
| Teleflex (TFX) | United States | $5.369B | 8.67 |
| Glaukos (GKOS) | United States | $5.223B | 0.00 |
| TransMedics (TMDX) | United States | $4.423B | 67.22 |
| Integer Holdings (ITGR) | United States | $3.741B | 18.67 |
| LivaNova (LIVN) | United Kingdom | $2.956B | 16.92 |
| Veracyte (VCYT) | United States | $2.363B | 32.65 |
| Alphatec Holdings (ATEC) | United States | $2.304B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.232B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.046B | 24.43 |
| Artivion (AORT) | United States | $2.027B | 102.26 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 16.93 |
| Pulse Biosciences (PLSE) | United States | $1.165B | 0.00 |
| OPKO Health (OPK) | United States | $1.072B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.061B | 6.08 |
| IRadimed (IRMD) | United States | $0.892B | 43.30 |
| Beta Bionics (BBNX) | United States | $0.726B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.720B | 0.00 |
| AxoGen (AXGN) | United States | $0.686B | 0.00 |
| SiBone (SIBN) | United States | $0.660B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.549B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.520B | 4.18 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.509B | 8.98 |
| OrthoPediatrics (KIDS) | United States | $0.480B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.439B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.373B | 9.50 |
| Pacific Biosciences Of California (PACB) | United States | $0.369B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 87.25 |
| AngioDynamics (ANGO) | United States | $0.355B | 0.00 |
| RxSight (RXST) | United States | $0.336B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.332B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.276B | 19.05 |
| Alpha Tau Medical (DRTS) | Israel | $0.271B | 0.00 |
| 908 Devices (MASS) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.235B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.207B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.191B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.113B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.106B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.101B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.092B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.057B | 0.00 |
| Positron (POSC) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.050B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.012B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.16 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |